The trials were led by Scott Rodeo, MD, at the Hospital for Special Surgery in New York. Dr. Rodeo serves as the co-chief of sports medicine and shoulder service at Hospital for Special Surgery and a professor of orthopedic surgery at Weill Cornell Medical College in New York.
The pre-clinical trials found evidence that PLX cells are a promising treatment for tendon and other orthopedic injuries.
More Articles on Sports Medicine:
Dr. Naven Duggal Joins Syracuse Orthopedic Specialists
9 Statistics on Orthopedic Surgeon Occupational Injury
Drs. Chad Price, Colin Crosby Join Elite Sports Medicine in Nashville
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
